By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Ono Pharmaceutical Company, Ltd. 

2-1-5 Doshomachi
Chuo-ku
Osaka    541-8526  Japan
Phone: 06-6222-5551 Fax:


SEARCH JOBS


Industry
Pharmaceutical






Company News
Ono Pharmaceutical Company, Ltd. And Gilead Sciences, Inc. (GILD) Announce Exclusive License Agreement To Develop BTK Inhibitor, ONO-4059, For The Treatment Of B-Cell Malignancies And Other Diseases 12/19/2014 11:44:30 AM
Ono Pharmaceutical Company, Ltd., Bristol-Myers Squibb Company (BMY), And Kyowa Hakko Kirin Announce Immuno-Oncology Clinical Collaboration Studying Opdivo (Nivolumab) And Mogamulizumab In Advanced Solid Tumors 12/10/2014 9:19:38 AM
Amgen (AMGN), Ono Pharmaceutical Company, Ltd., Sanofi (SAN.PA) Team Up With Academia On Proteins Project 10/28/2014 6:22:01 AM
Bristol-Myers Squibb Company (BMY) And Ono Pharmaceutical Company, Ltd. Announce Strategic Immuno-Oncology Collaboration In Japan, South Korea And Taiwan 7/24/2014 11:34:28 AM
Merck KGaA (MKGAF.PK) Terminates Multiple Schlerosis Drug License Agreement With Ono Pharmaceutical Company, Ltd. 6/17/2014 7:12:35 AM
Albany Molecular Research, Inc. (AMRI) (AMRI) and Ono Pharmaceutical Company, Ltd. Broaden SMARTSOURCING™ Collaboration 4/24/2013 9:39:45 AM
Receptos Determines Novel GPCR Structure, Achieves Key Milestone in Collaboration With Ono Pharmaceutical Company, Ltd. 3/7/2013 10:12:12 AM
Domain Therapeutics Enters Into Collaboration Agreement With Ono Pharmaceutical Company, Ltd. in the Field of GPCR-Based Drug Discovery 10/23/2012 9:47:01 AM
Galapagos NV (GLPG.BR) Subsidiary BioFocus DPI and Ono Pharmaceutical Company, Ltd. Sign a Drug Discovery Agreement in the Field of CNS Disorders 9/4/2012 9:10:46 AM
Ono Pharmaceutical Company, Ltd. and Galapagos NV (GLPG.BR) Subsidiary BioFocus DPI Sign an Additional Target Discovery Agreement in the Field of Allergic Disease 5/30/2012 6:49:50 AM
123456
//-->